Author

Beatriz Mínguez Rodríguez

EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE
EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE

Beatriz Mínguez Rodríguez  et al.

Item 1 - 1 / 1
1